| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
|
N Engl J Med
|
2003
|
8.87
|
|
2
|
Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.
|
Endocrinology
|
2004
|
3.89
|
|
3
|
Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.
|
Kidney Int
|
2003
|
3.75
|
|
4
|
Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile.
|
Nat Genet
|
2011
|
2.73
|
|
5
|
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis.
|
JAMA
|
2008
|
2.52
|
|
6
|
Older men with low serum estradiol and high serum SHBG have an increased risk of fractures.
|
J Bone Miner Res
|
2008
|
2.44
|
|
7
|
Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.
|
J Endocrinol
|
2007
|
2.31
|
|
8
|
Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men.
|
J Bone Miner Res
|
2009
|
2.20
|
|
9
|
Population genomics in a disease targeted primary cell model.
|
Genome Res
|
2009
|
2.20
|
|
10
|
Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden.
|
J Bone Miner Res
|
2006
|
1.91
|
|
11
|
High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden.
|
J Am Coll Cardiol
|
2011
|
1.81
|
|
12
|
COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.
|
Hum Mutat
|
2011
|
1.77
|
|
13
|
Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden.
|
J Am Coll Cardiol
|
2007
|
1.75
|
|
14
|
Genetic determinants of trabecular and cortical volumetric bone mineral densities and bone microstructure.
|
PLoS Genet
|
2013
|
1.64
|
|
15
|
Tissue effect on genetic control of transcript isoform variation.
|
PLoS Genet
|
2009
|
1.59
|
|
16
|
Assessment of gene-by-sex interaction effect on bone mineral density.
|
J Bone Miner Res
|
2012
|
1.58
|
|
17
|
Rats treated with AZD2858, a GSK3 inhibitor, heal fractures rapidly without endochondral bone formation.
|
Bone
|
2013
|
1.48
|
|
18
|
Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS).
|
Calcif Tissue Int
|
2009
|
1.47
|
|
19
|
Genetic determinants of serum testosterone concentrations in men.
|
PLoS Genet
|
2011
|
1.45
|
|
20
|
Effects of denosumab on fracture and bone mineral density by level of kidney function.
|
J Bone Miner Res
|
2011
|
1.40
|
|
21
|
Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.
|
Arterioscler Thromb Vasc Biol
|
2010
|
1.34
|
|
22
|
Low serum testosterone and estradiol predict mortality in elderly men.
|
J Clin Endocrinol Metab
|
2009
|
1.23
|
|
23
|
Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women.
|
Eur J Endocrinol
|
2004
|
1.19
|
|
24
|
The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.
|
J Clin Endocrinol Metab
|
2007
|
1.19
|
|
25
|
Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23.
|
Nephrol Dial Transplant
|
2007
|
1.18
|
|
26
|
Regulation of fibroblast growth factor-23 in chronic kidney disease.
|
Nephrol Dial Transplant
|
2007
|
1.12
|
|
27
|
Genome-wide association meta-analysis of cortical bone mineral density unravels allelic heterogeneity at the RANKL locus and potential pleiotropic effects on bone.
|
PLoS Genet
|
2010
|
1.10
|
|
28
|
Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
|
Eur J Endocrinol
|
2008
|
1.10
|
|
29
|
Characterization of patients in the European Forsteo Observational Study (EFOS): postmenopausal women entering teriparatide treatment in a community setting.
|
Curr Med Res Opin
|
2008
|
1.10
|
|
30
|
Systematic assessment of the human osteoblast transcriptome in resting and induced primary cells.
|
Physiol Genomics
|
2008
|
1.09
|
|
31
|
Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men.
|
J Bone Miner Res
|
2011
|
1.08
|
|
32
|
Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium.
|
Hum Mol Genet
|
2014
|
1.02
|
|
33
|
Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study.
|
J Bone Miner Res
|
2011
|
1.01
|
|
34
|
Preoperative tumor localization by means of venous sampling for fibroblast growth factor-23 in a patient with tumor-induced osteomalacia.
|
Endocr Pract
|
2008
|
0.97
|
|
35
|
Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men.
|
J Clin Endocrinol Metab
|
2008
|
0.95
|
|
36
|
Increased rate of bone loss at the femoral neck in patients with chronic liver disease.
|
Eur J Gastroenterol Hepatol
|
2002
|
0.94
|
|
37
|
IL6 and IL1B polymorphisms are associated with fat mass in older men: the MrOS Study Sweden.
|
Obesity (Silver Spring)
|
2008
|
0.93
|
|
38
|
Fibroblast growth factor-23 and mineral metabolism after unilateral nephrectomy.
|
Nephrol Dial Transplant
|
2010
|
0.93
|
|
39
|
Associations of estradiol and testosterone with serum phosphorus in older men: the Osteoporotic Fractures in Men study.
|
Kidney Int
|
2010
|
0.93
|
|
40
|
High serum adiponectin predicts incident fractures in elderly men: Osteoporotic fractures in men (MrOS) Sweden.
|
J Bone Miner Res
|
2012
|
0.92
|
|
41
|
Six months of hormone replacement therapy does not influence muscle strength in postmenopausal women.
|
Maturitas
|
2002
|
0.91
|
|
42
|
Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia.
|
Eur J Endocrinol
|
2003
|
0.89
|
|
43
|
Smoking predicts incident fractures in elderly men: Mr OS Sweden.
|
J Bone Miner Res
|
2010
|
0.88
|
|
44
|
Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men.
|
J Bone Miner Res
|
2007
|
0.87
|
|
45
|
Use of a Swedish T-score reference population for women causes a two-fold increase in the amount of postmenopausal Swedish patients that fulfill the WHO criteria for osteoporosis.
|
J Clin Densitom
|
2008
|
0.87
|
|
46
|
Inferior physical performance test results of 10,998 men in the MrOS Study is associated with high fracture risk.
|
Age Ageing
|
2012
|
0.86
|
|
47
|
Disturbances of calcium homeostasis consistent with mild primary hyperparathyroidism in premenopausal women and associated morbidity.
|
J Clin Endocrinol Metab
|
2007
|
0.86
|
|
48
|
Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men.
|
J Clin Endocrinol Metab
|
2010
|
0.86
|
|
49
|
Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS).
|
Calcif Tissue Int
|
2012
|
0.85
|
|
50
|
Serum insulin-like growth factor-I concentration is associated with leukocyte telomere length in a population-based cohort of elderly men.
|
J Clin Endocrinol Metab
|
2009
|
0.84
|
|
51
|
Low calcaneal bone mineral density and the risk of distal forearm fracture in women and men: a population-based case-control study.
|
Bone
|
2009
|
0.83
|
|
52
|
GSK-3 inhibition by an orally active small molecule increases bone mass in rats.
|
Bone
|
2011
|
0.82
|
|
53
|
Serum estradiol is associated with lean mass in elderly Swedish men.
|
Eur J Endocrinol
|
2010
|
0.82
|
|
54
|
Vitamin D receptor 3' haplotypes are unequally expressed in primary human bone cells and associated with increased fracture risk: the MrOS Study in Sweden and Hong Kong.
|
J Bone Miner Res
|
2007
|
0.81
|
|
55
|
Androgens and glucuronidated androgen metabolites are associated with metabolic risk factors in men.
|
J Clin Endocrinol Metab
|
2007
|
0.81
|
|
56
|
Osteoprotegerin secretion from prostate cancer is stimulated by cytokines, in vitro.
|
Biochem Biophys Res Commun
|
2002
|
0.81
|
|
57
|
Cost effectiveness of teriparatide and PTH(1-84) in the treatment of postmenopausal osteoporosis.
|
J Med Econ
|
2010
|
0.81
|
|
58
|
Heterozygosity for a coding SNP in COL1A2 confers a lower BMD and an increased stroke risk.
|
Biochem Biophys Res Commun
|
2009
|
0.80
|
|
59
|
The COMT val158met polymorphism is associated with prevalent fractures in Swedish men.
|
Bone
|
2007
|
0.80
|
|
60
|
Common sequence variation in FLNB regulates bone structure in women in the general population and FLNB mRNA expression in osteoblasts in vitro.
|
J Bone Miner Res
|
2009
|
0.80
|
|
61
|
Estimation of physical performance and measurements of habitual physical activity may capture men with high risk to fall--data from the Mr Os Sweden cohort.
|
Arch Gerontol Geriatr
|
2008
|
0.80
|
|
62
|
Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden.
|
World J Surg
|
2011
|
0.79
|
|
63
|
Expression of markers of activity in cultured human osteoblasts: effects of interleukin-4 and interleukin-13.
|
Scand J Clin Lab Invest
|
2010
|
0.79
|
|
64
|
Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial.
|
Bone
|
2008
|
0.78
|
|
65
|
Allele dependent silencing of COL1A2 using small interfering RNAs.
|
Int J Med Sci
|
2008
|
0.78
|
|
66
|
Expression of RANK-ligand in prostate cancer cell lines.
|
Scand J Clin Lab Invest
|
2009
|
0.78
|
|
67
|
A TA-repeat polymorphism in the gene for the estrogen receptor alpha does not correlate with muscle strength or body composition in young adult Swedish women.
|
Maturitas
|
2005
|
0.77
|
|
68
|
There is in elderly men a group difference between fallers and non-fallers in physical performance tests.
|
Age Ageing
|
2011
|
0.77
|
|
69
|
Interleukin-4 and interleukin-13 potentiate interleukin-1 induced secretion of interleukin-6 in human osteoblast-like cells.
|
J Orthop Res
|
2004
|
0.77
|
|
70
|
Bone formation in interleukin-4 and interleukin-13 depleted mice.
|
Acta Orthop
|
2008
|
0.76
|
|
71
|
Calcium and vitamin D for prevention of osteoporotic fractures.
|
Lancet
|
2007
|
0.75
|
|
72
|
[FRAX--model for 10-year fracture risk assessment. Support in the treatment of osteoporosis, according to preliminary Swedish guidelines].
|
Lakartidningen
|
2011
|
0.75
|
|
73
|
[SBU's conclusions concerning vitamin D and calcium treatment unchanged].
|
Lakartidningen
|
2007
|
0.75
|
|
74
|
The impact of estradiol on bone mineral density is modulated by the specific estrogen receptor-alpha cofactor retinoblastoma-interacting zinc finger protein-1 insertion/deletion polymorphism.
|
J Clin Endocrinol Metab
|
2007
|
0.75
|
|
75
|
[New evidence in SBU report on vitamin D and calcium. The risk of fracture is reduced by treatment in women older than 80 years--but not in younger ones].
|
Lakartidningen
|
2007
|
0.75
|
|
76
|
[Bone remodeling].
|
Lakartidningen
|
2006
|
0.75
|
|
77
|
[Osteomalacia due to phosphate deficiency caused by a tumor. Focus on FGF23 in physiology and clinic].
|
Lakartidningen
|
2012
|
0.75
|